Amyotrophic Lateral Sclerosis: Therapeutic Innovations and Evolving Regulatory Approaches.
New ALS therapies including gene therapy and antisense drugs are expanding treatment options for this devastating neurodegenerative disease.
This narrative review summarizes therapeutic innovations in ALS including gene therapy, ASOs, and new molecular targets, alongside evolving regulatory frameworks for accelerated approval. Review design limits evidence strength but is informative for ALS rare disease surveillance.
What the study was
- Study design
- Narrative review
- Population
- ALS patients
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- CNS & Neurological Disorders Drug Targets
Why it surfaced
ALS is a rare, high-unmet-need disease; review provides good surveillance signal. Score 5 per review rules.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.